NCT06741020View on ClinicalTrials.gov

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 30, 2026

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
DRUG

Adebrelimab, Oxaliplatin, Fluorouracil,Leucovorin

Chemotherapy drugs including Oxaliplatin, Fluorouracil,Leucovorin and immunotherapy durgs Adebrelimab will infuse to liver by transarterial catheter toward to the lesion.

Trial Locations (2)

310002

NOT_YET_RECRUITING

Zhejiang Cancer Hospital, Hangzhou

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER